돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 55038생성일: 2026년 10월 25일

7-(Benzyloxy)-4-chloro-6-methoxyquinazoline → 3-[1-(7-Benzyloxy-6-methoxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxoquinazoline

https://huagongshe.com/reaction/55038

반응식

참여 물질

역할이름HCID투입량
반응물7-(Benzyloxy)-4-chloro-6-methoxyquinazolineHCID 10661998—
반응물1,2,3,4-Tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromideHCID 21851222—
생성물3-[1-(7-Benzyloxy-6-methoxy-4-quinazolinyl)-4-piperidinyl]-1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxoquinazolineHCID 2292343642%

반응 단계

The procedure similar to that described in Example 57 was repeated, except that 369.0 mg (1.05 mmol) of 1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)-quinazoline hydrobromide (Compound v) obtained in Example 41 was used and 7-benzyloxy-4-chloro-6-methoxyquinazoline was used in place of 4-chloro-6,7-dimethoxyquinazoline. As a result, 233.8 mg (yield: 42%) of Compound 87 was obtained as white crystals.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05624926
출처 데이터셋uspto-grants-1997_04
ORD IDord-9de39fc1549d47039b22cbe18030dffd
출처 메모uspto-grants-1997_04